Press release
United States Digital Biomarkers in Oncology Clinical Trails Market 2025 | Latest Developments, and Major key players - Koneksa Healthcare, IBM Watson Health, Philips Healthcare.
Market Overview:The Global Digital Biomarkers in Oncology Clinical Trails Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
The Digital Biomarkers in Oncology Clinical Trails Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/digital-biomarkers-in-oncology-clinical-trails-market?sz
The Digital Biomarkers in Oncology Clinical Trials Market refers to the sector focused on using digital tools such as wearable devices, sensors, and mobile applications to collect objective, quantifiable data on patients' physiological and behavioral health. These biomarkers aid in monitoring treatment response, predicting outcomes, and improving trial efficiency, accuracy, and personalized cancer care, transforming oncology research and drug development processes.
Industry Recent Developments:
United States:
✅ May 2025: The Digital Biomarkers Summit USA 2025 focused on collaboration in digital measurement and endpoints in clinical trials, highlighting recent case studies and patient-centered approaches.
✅ March 2025: BostonGene announced a collaboration to evaluate biomarkers for colorectal cancer and multiple myeloma using AI-driven molecular profiling in clinical trials.
✅ April - August 2025: The U.S. digital biomarkers market and clinical research environment saw increasing adoption of AI and digital health solutions to improve oncological trial efficiency and precision.
Japan:
✅ March 2025: Lunit, a key AI company, announced a collaboration with the U.S. National Cancer Institute (NCI) to explore innovative AI applications in cancer research.
✅ August 2025: Takeda Pharmaceutical explored conducting global clinical trials in India to accelerate oncology drug launches, reflecting Japan's strategy to globalize clinical trial efforts.
✅ March 2025: Blackstone Inc. acquired a 60% stake in CMIC Co., a Tokyo-based clinical trial company supporting drugmakers, signaling increased private equity interest and regulatory reforms boosting clinical trial efficiency in Japan.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/digital-biomarkers-in-oncology-clinical-trails-market?sz
Major Key Players:
Koneksa Healthcare
Medidata Solutions, Inc
IBM Watson Health
Philips Healthcare
Syneos Health
Oracle Corporation
Pfizer Inc
NantHealth
Medtronic
Curemetrix.
Key Growth Drivers:
Continuous Monitoring and Real-Time Data: Digital biomarkers enable continuous, high-resolution, and objective monitoring of patients' physiologic and behavioral data, which allows for more accurate and comprehensive assessment of cancer treatment effects compared to traditional intermittent clinical evaluations.
Integration into Decentralized Clinical Trials: The growing adoption of decentralized and hybrid clinical trial models incorporating digital biomarkers improves patient recruitment, retention, and convenience while reducing trial timelines accelerating drug development and regulatory approvals.
Advances in Technology and Regulatory Support: Innovations in wearable devices, mobile health platforms, multi-omics approaches, and AI-driven analytics together with progressive regulatory guidelines are fostering greater acceptance, validation, and commercialization of digital biomarkers for oncology trials.
Segments Covered in the Digital Biomarkers in Oncology Clinical Trails Market:
By Product Type: Wearable Devices, Mobile Health Apps, Electronic Health Records (EHRs), Others.
By Application: Market Attractiveness Index, By Application, Early Detection & Diagnosis, Treatment Monitoring, Patient Management, Outcome Prediction.
By End User: Pharmaceutical & Biotechnology Companies, Research Institutions, Hospitals and Clinics.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=digital-biomarkers-in-oncology-clinical-trails-market
Chapter Outline
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Digital Biomarkers in Oncology Clinical Trails market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Digital Biomarkers in Oncology Clinical Trails Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The Global Digital Biomarkers in Oncology Clinical Trails market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Digital Biomarkers in Oncology Clinical Trails Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Digital Biomarkers in Oncology Clinical Trails Market in 2025?
◆ What is the projected growth rate of the Digital Biomarkers in Oncology Clinical Trails Market through 2033?
◆ Who are the key players in the Digital Biomarkers in Oncology Clinical Trails Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Digital Biomarkers in Oncology Clinical Trails Market 2025 | Latest Developments, and Major key players - Koneksa Healthcare, IBM Watson Health, Philips Healthcare. here
News-ID: 4222507 • Views: …
More Releases from DataM Intelligence 4Market Research

United States Veterinary API Market is expected to reach US$ 12.29 Billion by 20 …
Market Size and Forecast:
The Global Veterinary API Market Size reached US$ 6.84 billion in 2023 and is expected to reach US$ 12.29 billion by 2031, growing with a CAGR of 7.6% during the forecast period 2024-2031.
The Veterinary API Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…

United States Fasciotomy Market is expected to reach US$ 6.68 Billion by 2031 | …
Market Size and Forecast:
The Global Fasciotomy Market Size reached US$ 4.15 billion in 2023 and is expected to reach US$ 6.68 billion by 2031, growing at a CAGR of 6.3% during the forecast period 2024-2031.
The Fasciotomy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and…

United States Reb M Market is expected to reach US$ 107.75 Million by 2031 | Maj …
Market Size and Forecast:
The Global Reb M Market Size reached US$ 73.38 million in 2023 and is expected to reach US$ 107.75 million by 2031, growing at a CAGR of 4.92% during the forecast period 2024-2031.
The Reb M Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…

United States Convenience Stores Market is expected to reach US$ 1,091.92 Billio …
Market Size and Forecast:
The Global Convenience Stores Market Size reached US$659.32 billion in 2024 and is expected to reach US$1,091.92 billion by 2032, growing with a CAGR of 6.51% during the forecast period 2025-2032.
The Convenience Stores Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and…
More Releases for Digital
Introducing Digital Sales Pro, Inc: Revolutionizing Digital Sales in the Digital …
Digital Sales Pro, Inc. is a company that helps content creators and publishers make money from content and reach a larger audience with their craft.
In today's world, it can be tough for content creators and publishers to make money and connect with their audience.
At, Digital Sales Pro, Inc. we understand these challenges and have created a suite of solutions that help our clients build a strong online presence, monetize…
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
Introduction
The healthcare industry has seen significant growth and development over the years, with technology playing a critical role in transforming patient care. One such innovative technology that has emerged in recent years is the Global Digital Twin in Healthcare Market. This technology allows healthcare professionals to create a virtual replica of a patient's physical self, enabling them to monitor and analyze patient data in real-time. The Global Digital Twin in…
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
In 2021, the market for Digital Twin in Healthcare worldwide was worth $6.75 billion US dollars. AMR Group projects that the market will reach US$ 96.5 billion by 2031, growing at a CAGR of 40 percent between 2022 and 2031.
Industry Overview
Digital twins are virtual copies of physical objects or things that data scientist & IT professionals can use to compute simulations prior to developing and deploying the original devices. Digital…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
Digital Advertising on Mobil Market Analysis 2019 Top Growing Companies: Adverti …
Digital Advertising on Mobil Market
Digital Advertising on Mobile Market is a type of advertising that shows that mobile devices such as smart phones and tablets have wireless connectivity. For mobile devices with fewer lenses than computers or laptops, digital media formats are often the most suitable for small displays through outputs. Telephone advertising is the communication of products or services of mobile devices and consumers. Telephone announcements range from…
Digital Display Market Future Growth with Worldwide Players (Digital Virgo, Digi …
Digital Display Industry 2019 Global Market 2025 research report represents the historical overview of current Market situation, size, share, trends, growth, supply, outlook and manufacturers with detailed analysis. It also focuses on Digital Display volume and value at global level, regional level and company level. From a global perspective, this report represents overall Digital Display market size by analyzing historical data and future prospect.
Get Sample Copy of this Report -…